Paper35202128
Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings.
Nguyen C and 3 others. Toxins (Basel), 2022. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings. Papers, record 35202128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35202128
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aorta, Thoracic | Major topic |
| Azo Compounds | Major topic |
| Endothelium, Vascular | Major topic |
| Indican | Major topic |
| Pyrazoles | Major topic |
| Receptors, Aryl Hydrocarbon | Major topic |
| Animals | |
| Cytochrome P-450 CYP1A1 | |
| Gene Expression | |
| Male | |
| Oxidative Stress | |
| Rats, Sprague-Dawley | |
| Reactive Oxygen Species | |
| Renal Insufficiency, Chronic | |
| Vasodilation | |
| Rats |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33020564 | Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure. | Sci Rep | 2020 | https://conductscience.org/library/papers/33020564 | PubMed |
| 2 | 27829840 | Antioxidant Functions of the Aryl Hydrocarbon Receptor. | Stem Cells Int | 2016 | https://conductscience.org/library/papers/27829840 | PubMed |
| 3 | 20937831 | Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20937831 | PubMed |
| 4 | 22288014 | Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease. | Int J Nephrol | 2012 | https://conductscience.org/library/papers/22288014 | PubMed |
| 5 | 18850075 | Hypertension, cardiac hypertrophy, and impaired vascular relaxation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are associated with increased superoxide. | Cardiovasc Toxicol | 2008 | https://conductscience.org/library/papers/18850075 | PubMed |
| 6 | 21784828 | The microvasculature in chronic kidney disease. | Clin J Am Soc Nephrol | 2011 | https://conductscience.org/library/papers/21784828 | PubMed |
| 7 | 20047993 | Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? | Eur Heart J | 2010 | https://conductscience.org/library/papers/20047993 | PubMed |
| 8 | 29449538 | Downregulation of PERK activity and eIF2α serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29449538 | PubMed |
| 9 | 25349205 | Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD. | J Am Soc Nephrol | 2015 | https://conductscience.org/library/papers/25349205 | PubMed |
| 10 | 19696217 | Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. | Clin J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19696217 | PubMed |
| 11 | 32260489 | Indoxyl Sulfate, a Uremic Endotheliotoxin. | Toxins (Basel) | 2020 | https://conductscience.org/library/papers/32260489 | PubMed |
| 12 | 25244654 | Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand. | PLoS One | 2014 | https://conductscience.org/library/papers/25244654 | PubMed |
| 13 | 23139286 | Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. | Circ Res | 2012 | https://conductscience.org/library/papers/23139286 | PubMed |
| 14 | 26408929 | Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120. | Atherosclerosis | 2015 | https://conductscience.org/library/papers/26408929 | PubMed |
| 15 | 14672759 | Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. | Life Sci | 2004 | https://conductscience.org/library/papers/14672759 | PubMed |
| 16 | 19215692 | Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure. | J Int Med Res | 2009 | https://conductscience.org/library/papers/19215692 | PubMed |
| 17 | 27189289 | AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving Hemodialysis. | Yonsei Med J | 2016 | https://conductscience.org/library/papers/27189289 | PubMed |
| 18 | 17498000 | AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases. | Ther Apher Dial | 2007 | https://conductscience.org/library/papers/17498000 | PubMed |
| 19 | 24349545 | The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction. | PLoS One | 2013 | https://conductscience.org/library/papers/24349545 | PubMed |
| 20 | 21682773 | Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction. | Semin Dial | 2011 | https://conductscience.org/library/papers/21682773 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650821 | Mechanisms of Obesity-Related Kidney Disease: From Adipose Depot Biology to the Chymase-Aldosterone and Ghrelin-Leptin Axes. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650821 | PubMed |
| 42591525 | The gut microbiota-aromatic amino acid axis in cardiovascular disease: pathophysiological roles, translational biomarkers, and therapeutic targeting. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42591525 | PubMed |
| 42353310 | Decoding the Gut-Fat-Heart Axis: From Molecular Communication Networks to Clinical Translation Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353310 | PubMed |
| 42352052 | Redox Network Failure in Chronic Kidney Disease: Hydrogen Sulfide Deficiency, Reactive Sulfur Species Dysregulation and the Uremic Toxin-AhR-Mitochondrial Axis. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42352052 | PubMed |
| 42289169 | VSMC-derived 3HAA activates AhR to drive abdominal aortic aneurysm formation via the p62-Nrf2 axis. | Redox Biol | 2026 | https://conductscience.org/library/papers/42289169 | PubMed |
| 41830551 | Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host. | Gut Microbes | 2026 | https://conductscience.org/library/papers/41830551 | PubMed |
| 41614946 | Aryl Hydrocarbon Receptor (AhR) and Vascular Endothelial Growth Factor (VEGF) Crosstalk in Doxorubicin Nephrotoxicity: Mechanisms and Therapeutic Perspectives. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41614946 | PubMed |
| 41596404 | Thrombospondin 1-CD47 Signalling Modulates Vascular Smooth Muscle Cell Senescence in Chronic Kidney Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596404 | PubMed |
| 41195389 | Unraveling the mysteries of the gut-kidney axis: the protective role of traditional Chinese medicine in chronic kidney disease. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41195389 | PubMed |
| 40864097 | Kynurenine Promotes Phosphate-Induced Endothelial Calcification via Endothelial-to-Mesenchymal Transition, Osteoblastic Differentiation and AhR Activation. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40864097 | PubMed |
| 40066951 | Inhibition of 5-hydroxyindoleacetic acid to reduce neutrophil extracellular trap production improves lung condition in chronic obstructive pulmonary disease mice. | Ann Med | 2025 | https://conductscience.org/library/papers/40066951 | PubMed |
| 39684480 | Redefining Roles: A Paradigm Shift in Tryptophan-Kynurenine Metabolism for Innovative Clinical Applications. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684480 | PubMed |
| 39591217 | Future of Uremic Toxin Management. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39591217 | PubMed |
| 39451248 | Molecular Mechanisms of Skatole-Induced Inflammatory Responses in Intestinal Epithelial Caco-2 Cells: Implications for Colorectal Cancer and Inflammatory Bowel Disease. | Cells | 2024 | https://conductscience.org/library/papers/39451248 | PubMed |
| 39439463 | Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways. | Int J Med Sci | 2024 | https://conductscience.org/library/papers/39439463 | PubMed |
| 39113916 | Natural antagonistic flavones for AhR inhibit indoxyl sulfate-induced inflammatory gene expression in vitro and renal pathological damages in vivo. | Food Nutr Res | 2024 | https://conductscience.org/library/papers/39113916 | PubMed |
| 37814337 | The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease. | J Transl Med | 2023 | https://conductscience.org/library/papers/37814337 | PubMed |
| 37789009 | Gut microbe-derived metabolite indole-3-carboxaldehyde alleviates atherosclerosis. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37789009 | PubMed |
| 37686342 | The Role of Aryl Hydrocarbon Receptor in the Endothelium: A Systematic Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686342 | PubMed |
| 37651204 | Breaking bugs: gut microbes metabolize dietary components and modulate vascular health. | Crit Rev Food Sci Nutr | 2024 | https://conductscience.org/library/papers/37651204 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35202128
GET https://conductscience.org/api/papers/v1/35202128/references?page=2